From October 14, 2021 to April 13, 2022, the company has repurchased 251,612 shares, representing 0.89% for KRW 1,997.79 million. With this, the company has completed the repurchase of 251,612 shares, representing 0.89% for KRW 1,997.79 million under the buyback announced on October 14, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,790 KRW | +0.44% | -5.43% | +19.96% |
1st Jan change | Capi. | |
---|---|---|
+19.96% | 135M | |
+39.82% | 734B | |
+32.83% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+14.19% | 238B | |
-6.26% | 204B | |
+8.70% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- A006620 Stock
- News DongKoo Bio & Pharma Co., Ltd.
- Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on October 14, 2021.